Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine

BACKGROUND: A new coronavirus SARS-CoV-2 has been identified as the etiological agent of the severe acute respiratory syndrome, COVID-19, the source and cause of the 2019–20 coronavirus pandemic. Hydroxychloroquine and chloroquine have gathered extraordinary attention as therapeutic candidates again...

Descripción completa

Detalles Bibliográficos
Autores principales: Babayeva, Mariana, Loewy, Zvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591012/
https://www.ncbi.nlm.nih.gov/pubmed/33122936
http://dx.doi.org/10.2147/PGPM.S275964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591012/
https://www.ncbi.nlm.nih.gov/pubmed/33122936
http://dx.doi.org/10.2147/PGPM.S275964

Ejemplares similares